Globally recognized leader in early-phase oncology clinical development and experimental therapeuticsStrengthens strategic ...
When Vera Therapeutics in-licensed atacicept from Merck KGaA about six years ago, patients with IgA nephropathy (IgAN) had no ...
Potentially first-in-class oral TNIK inhibitor advances into late-stage development after milestones marked by vital ...
The experience of the GT3 Sport Cabriolet is only enhanced by the power-operated roof, but the big challenge will likely be ...
The 55th Annual Conference of the Fraunhofer Institute for Chemical Technology ICT, titled “Energetic Materials: From Simulation and Synthesis to Application – Ensuring Supply Security in a Changing ...
Morning Overview on MSN
A nasal spray reversed signs of brain aging in early tests, and a patent is already filed
Researchers at Texas A&M University reported that two intranasal doses of extracellular vesicles derived from human neural ...
A newly found chain-reaction phase change in 2D MoTe2 lowers energy barriers, enabling faster control of electronic and ...
A newly developed material can control and "program" heat, allowing it to direct thermal radiation, switch modes, and ...
Cancer remains notoriously difficult to treat, partly because tumors co‑opt their surrounding environment, including the ...
The gut microbiome is no longer viewed as a mere spectator in cancer development – it is increasingly recognized as a key ...
Background Janus kinase inhibitors (JAKis) are emerging therapies for SLE, but concerns regarding thromboembolic risk persist ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results